HOOKIPA Pharma Inc. Annual Operating Income (Loss) in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HOOKIPA Pharma Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2024.
  • HOOKIPA Pharma Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$21.5M, a 30.5% increase year-over-year.
  • HOOKIPA Pharma Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$51.5M, a 47.3% increase year-over-year.
  • HOOKIPA Pharma Inc. annual Operating Income (Loss) for 2024 was -$51.5M, a 47.3% increase from 2023.
  • HOOKIPA Pharma Inc. annual Operating Income (Loss) for 2023 was -$97.7M, a 33.5% decline from 2022.
  • HOOKIPA Pharma Inc. annual Operating Income (Loss) for 2022 was -$73.2M, a 10.4% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$51.5M +$46.2M +47.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-28
2023 -$97.7M -$24.5M -33.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-28
2022 -$73.2M +$8.52M +10.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-28
2021 -$81.7M -$28.4M -53.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-22
2020 -$53.3M -$2.2M -4.31% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 -$51.1M -$29.9M -141% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-24
2018 -$21.2M -$7.02M -49.6% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-18
2017 -$14.2M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.